SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-317234
Filing Date
2017-10-24
Accepted
2017-10-24 06:32:48
Documents
5
Period of Report
2017-10-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d480657d8k.htm 8-K 20464
2 EX-10.1 d480657dex101.htm EX-10.1 226949
3 EX-10.2 d480657dex102.htm EX-10.2 18708
4 EX-99.1 d480657dex991.htm EX-99.1 7131
5 GRAPHIC g480657001.jpg GRAPHIC 2154
  Complete submission text file 0001193125-17-317234.txt   277674
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 171149906
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1